{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:46:44Z","timestamp":1785336404596,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Xeroderma pigmentosum is a rare inherited disease characterized by extreme hypersensitivity to ultraviolet rays and predisposing to cutaneous malignancies that can appear in childhood. These manifestations are often associated with ocular lesions and sometimes with neurological disorders. The association of xeroderma pigmentosum with internal neoplasms such as acute myeloblastic leukemia is not reported with great frequency, which confirms the rarity of this occurrence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case report<\/jats:title>\n                <jats:p>A 26-year-old Moroccan women, xeroderma pigmentosum patient, was diagnosed with acute myeloblastic leukemia with a complex karyotype. Due to the adverse risk of the xeroderma pigmentosum association with acute myeloblastic leukemia and the profile of acute myeloblastic leukemia with complex karyotype and monosomy 7, which constitute factors of poor prognosis, as well as the absence of studies conceding the tolerance of the chemotherapy by patients suffering from xeroderma pigmentosum, our patient was put under low-dose cytarabine protocol with granulocyte colony-stimulating factor. Unfortunately, she died on the tenth day of chemotherapy by acute pulmonary edema of cardiogenic pace complicated by tamponade.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>According to reports, it is the second case showing association of xeroderma pigmentosum with acute myeloblastic leukemia. The management of these patients remains a challenge. Studies focusing on xeroderma pigmentosum patients developing hematological malignancies are necessary to better understand the most appropriate strategies and precautions for this specific case.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-02969-1","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T09:02:49Z","timestamp":1629968569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Xeroderma pigmentosum and acute myeloid leukemia: a case report\u00a0"],"prefix":"10.1186","volume":"15","author":[{"given":"H.","family":"Bencharef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lamchahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dassouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sraidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Guennoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Oukkache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Quessar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"issue":"11","key":"2969_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.annder.2018.09.004","volume":"145","author":"M Zghala","year":"2018","unstructured":"Zghala M, Fazaaa B, Abdelhakb S, Mokni M. Xeroderma pigmentosum. Ann Dermatol Venereol. 2018;145(11):706\u201322.","journal-title":"Ann Dermatol Venereol"},{"key":"2969_CR2","first-page":"21","volume":"2","author":"AK Bilodi","year":"2013","unstructured":"Bilodi AK, Gangadhar MR. Xeroderma pigmentosa. A rare clinical entity. Indian J Med Case Rep. 2013;2:21\u20134.","journal-title":"Indian J Med Case Rep"},{"key":"2969_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archderm.1987.01660260111026","volume":"123","author":"KH Kraemer","year":"1987","unstructured":"Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987;123:241\u201350.","journal-title":"Arch Dermatol"},{"key":"2969_CR4","first-page":"87","volume":"51","author":"L Feller","year":"2010","unstructured":"Feller L, Wood NH, Motswaledi MH, Khammissa RA, Meyer M, Lemmer J. Xeroderma pigmentosum: a case report and review of the literature. J Prev Med Hyg. 2010;51:87\u201391.","journal-title":"J Prev Med Hyg"},{"key":"2969_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/0378-6323.148559","volume":"81","author":"PM Tamhankar","year":"2015","unstructured":"Tamhankar PM, Iyer SV, Ravindran S, Gupta N, Kabra M, Nayak C, et\u00a0al. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients. Indian J Dermatol Venereol Leprol. 2015;81:16\u201322.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2969_CR6","unstructured":"Gharbi MR. Lexeroderma pigmentosum. Tunis: Editions SAGEP; 1980."},{"key":"2969_CR7","unstructured":"Zghal M, Fazaa B, Mokhtar I, Sarasin A, Nishigori C, Takebe H, et\u00a0al. Lexeroderma pigmentosum et ses particularit\u00e9s en Tunisie. In: Journ\u00e9es dermatologiques de Paris. Paris: Masson;1997. p. 134."},{"key":"2969_CR8","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/jid.2009.409","volume":"130","author":"N Soufir","year":"2010","unstructured":"Soufir N, Ged C, Bourillon A, Austerlitz F, Chemin C, Stary A, Armier J, Pham D, Khadir K, Roume J, et\u00a0al. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. J Invest Dermatol. 2010;130:1537\u201342.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2969_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000342897","volume":"129","author":"S Janjetovic","year":"2013","unstructured":"Janjetovic S, Bacher U, Haalck T, Janning M, Bokemeyer C, Fiedler W. Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects. Acta Haematol. 2013;129(2):121\u20135.","journal-title":"Acta Haematol"},{"key":"2969_CR10","first-page":"2","volume":"1","author":"M Chaudhary","year":"2012","unstructured":"Chaudhary M, Jajoo SN, Agarwal R. Xeroderma pigmentosum: a case report of two siblings. J Immunodefic Disord. 2012;1:2.","journal-title":"J Immunodefic Disord"},{"key":"2969_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1017\/S0021932009003393","volume":"41","author":"IC Jaouad","year":"2009","unstructured":"Jaouad IC, Elalaoui SC, Sbiti A, Elkerh F, Belmahi L, Sefiani A. Consanguineous marriages in Morocco and the consequence for the incidence of autosomal recessive disorders. J Biosoc Sci. 2009;41:575\u201381.","journal-title":"J Biosoc Sci"},{"key":"2969_CR12","first-page":"1974","volume":"60","author":"F Chavanne","year":"2000","unstructured":"Chavanne F, Broughton BC, Pietra D, Nardo T, Browitt A, Leh-mann AR, et\u00a0al. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res. 2000;60:1974\u201382.","journal-title":"Cancer Res"},{"key":"2969_CR13","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S1568-7864(03)00136-8","volume":"2","author":"JE Cleaver","year":"2003","unstructured":"Cleaver JE. Excision repair\u2014its bacterial beginnings. DNA Repair. 2003;2:1273\u20135.","journal-title":"DNA Repair"},{"key":"2969_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/jhg.2009.50","volume":"54","author":"M Ben Rekaya","year":"2009","unstructured":"Ben Rekaya M, Messaoud O, Talmoudi F, Nouira S, Ouragini H, Amouri A, et\u00a0al. High frequency of the V548A fs X572 XPC mutation in Tunisia: implication for molecular diagnosis. J Hum Genet. 2009;54:426\u20139.","journal-title":"J Hum Genet"},{"key":"2969_CR15","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/jid.2008.48","volume":"128","author":"H Inui","year":"2008","unstructured":"Inui H, Oh KS, Nadem C, Ueda T, Khan SG, Metin A, et\u00a0al. Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol. 2008;128:2055\u201368.","journal-title":"J Invest Dermatol"},{"key":"2969_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/hmg\/7.6.969","volume":"7","author":"Y Matsumura","year":"1998","unstructured":"Matsumura Y, Nishigori C, Yagi T, Imamura S, Takebe H. Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms. Hum Mol Genet. 1998;7:969\u201374.","journal-title":"Hum Mol Genet"},{"issue":"15","key":"2969_CR17","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.ejca.2008.06.024","volume":"44","author":"L Qiu","year":"2008","unstructured":"Qiu L, Wang Z, Shi X, et\u00a0al. Associations between XPC polymorphisms and risk of cancers: a meta-analysis. Eur J Cancer. 2008;44(15):2241\u201353.","journal-title":"Eur J Cancer"},{"issue":"8","key":"2969_CR18","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/ijc.28089","volume":"133","author":"J He","year":"2013","unstructured":"He J, Shi TY, Zhu ML, et\u00a0al. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis. Int J Cancer. 2013;133(8):1765\u201375.","journal-title":"Int J Cancer"},{"key":"2969_CR19","doi-asserted-by":"publisher","first-page":"9357","DOI":"10.1007\/s13277-016-4815-6","volume":"37","author":"C B\u0103nescu","year":"2016","unstructured":"B\u0103nescu C, Iancu M, Trifa AP, Dobreanu M, Moldovan VG, Duicu C, Tripon F, Crauciuc A, Skypnyk C, Bogli\u0219 A, Lazarm E. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population. Tumor Biol. 2016;37:9357\u201366.","journal-title":"Tumor Biol"},{"issue":"4","key":"2969_CR20","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3109\/10428190903582804","volume":"51","author":"SS Strom","year":"2010","unstructured":"Strom SS, Estey E, Outschoorn UM, et\u00a0al. Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients. Leuk Lymphoma. 2010;51(4):598\u2013605.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2969_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s12185-012-1145-3","volume":"96","author":"P Xu","year":"2012","unstructured":"Xu P, Chen B, Feng J, et\u00a0al. Polymorphisms in XPC provide prognostic information in acute myeloid leukemia. Int J Hematol. 2012;96(4):450\u201360.","journal-title":"Int J Hematol"},{"issue":"6","key":"2969_CR22","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3109\/10428194.2014.974045","volume":"56","author":"K Douzi","year":"2015","unstructured":"Douzi K, Ouerhani S, Menif S, Safra I, Abbes S. Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population. Leuk Lymphoma. 2015;56(6):1856\u201362.","journal-title":"Leuk Lymphoma"},{"key":"2969_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000342897","volume":"129","author":"S Janjetovic","year":"2013","unstructured":"Janjetovic S, Bacher U, Haalck T, Janning M, Bokemeyer C, Fiedler W. Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects. Acta Haematol. 2013;129:121\u20135.","journal-title":"Acta Haematol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02969-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02969-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02969-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T10:12:49Z","timestamp":1629972769000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02969-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2969"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02969-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"20 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"437"}}